Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.
Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE. Ellis LM, et al. Among authors: meropol nj. J Clin Oncol. 2014 Apr 20;32(12):1277-80. doi: 10.1200/JCO.2013.53.8009. Epub 2014 Mar 17. J Clin Oncol. 2014. PMID: 24638016 No abstract available.
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, Gradishar WJ, Green DM, Langdon RJ Jr, Mitchell RB, Negrin R, Szatrowski TP, Thigpen JT, Von Hoff D, Wasserman TH, Winer EP, Pfister DG. Hensley ML, et al. Among authors: meropol nj. J Clin Oncol. 1999 Oct;17(10):3333-55. doi: 10.1200/JCO.1999.17.10.3333. J Clin Oncol. 1999. PMID: 10506637
2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
Schuchter LM, Hensley ML, Meropol NJ, Winer EP; American Society of Clinical Oncology Chemotherapy and Radiotherapy Expert Panel. Schuchter LM, et al. Among authors: meropol nj. J Clin Oncol. 2002 Jun 15;20(12):2895-903. doi: 10.1200/JCO.2002.04.178. J Clin Oncol. 2002. PMID: 12065567 No abstract available.
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.
Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson AB 3rd, Castel L, Corbett S, Diefenbach M, Gaskin D, Li Y, Manne S, Marshall J, Rowland JH, Slater E, Sulmasy DP, Van Echo D, Washington S, Schulman KA. Meropol NJ, et al. J Clin Oncol. 2003 Jul 1;21(13):2589-96. doi: 10.1200/JCO.2003.10.072. J Clin Oncol. 2003. PMID: 12829680
Cost of cancer care: issues and implications.
Meropol NJ, Schulman KA. Meropol NJ, et al. J Clin Oncol. 2007 Jan 10;25(2):180-6. doi: 10.1200/JCO.2006.09.6081. J Clin Oncol. 2007. PMID: 17210937 Review.
End points in advanced colon cancer clinical trials: a review and proposal.
Allegra C, Blanke C, Buyse M, Goldberg R, Grothey A, Meropol NJ, Saltz L, Venook A, Yothers G, Sargent D. Allegra C, et al. Among authors: meropol nj. J Clin Oncol. 2007 Aug 20;25(24):3572-5. doi: 10.1200/JCO.2007.12.1368. J Clin Oncol. 2007. PMID: 17704403 Review. No abstract available.
293 results